Skip to main content

Rigel Pharmaceuticals Inc

RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001034842

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

Members of Congress who traded RIGL

No member of Congress has reported a trade in Rigel Pharmaceuticals Inc since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.